Next fall’s new COVID vaccine will be different
Kristopher Radder/The Brattleboro Reformer via AP FILE – Crager Boardman, from Brattleboro, Vt., receives a shot at a flu vaccine...
Social Impact
FDA panel recommends new COVID-19 shots to target the Omicron variant
BREAKING NEWS: FDA recommends new COVID-19 shots to target Omicron with jabs expected to rollout in OctoberThe FDA's leading vaccine...
FDA Panel Meeting for Discussion If Next Generation Vaccines Should Target Omicron
© Caroline Brehman/EPA, via Shutterstock A healthcare worker prepares a Pfizer-BioNTech coronavirus booster shot in Los Angeles earlier this year....
News Scan for Jun 28, 2022
Study: In most young adults, COVID-19 infectious period lasts only 5 daysA new study from researchers at Boston University (BU)...
FDA advisers call for Omicron update for COVID boosters
The Food and Drug Administration (FDA) outside advisory committee today recommended that new booster shot versions include an Omicron variant...
An FDA Panel Decides It’s Time For New COVID-19 Boosters
On June 28, a panel of experts convened by the U.S. Food and Drug Administration (FDA) voted 19 to 2...
Novavax COVID-19 Data Presented at FDA VRBPAC Meeting Demonstrates Broad Antibody Responses to Both Prototype and Omicron-Specific Variants
Novavax prototype vaccine (NVX-CoV2373) demonstrates broad immune responses including against Omicron and other circulating variantsPre-clinical data demonstrated that boosting with...
FDA advisers recommend updating COVID booster shots for fall
At least some U.S. adults may get updated COVID-19 shots this fall, as government advisers voted Tuesday that it's time...
COVID in California: Over 10 million Californians infected since pandemic started
Fewer than 34% of eligible Americans have received life-saving booster shots Just over a third, 33.6%, of eligible Americans have...
Fall COVID vaccine should target omicron variant, FDA panel advises
A federal advisory panel voted 19-2 Tuesday to reformulate COVID-19 booster shots for the fall to more directly target the omicron...